NCT00864643 - Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia | Biotech Hunter

Enrollment

172

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Hypercholesterolemia

Interventions

DRUG

Lapaquistat acetate and atorvastatin

Lapaquistat acetate 100 mg, tablets, orally, once daily and atorvastatin 10 mg or 20 mg, tablets, orally, once daily for up to 6 weeks.

DRUG

Atorvastatin

Lapaquistat acetate placebo-matching tablets, orally, once daily and atorvastatin 10 mg or 20 mg, tablets, orally, once daily for up to 6 weeks.